Bio-Techne
TECH
#1410
Rank
NZ$20.60 B
Marketcap
$129.89
Share price
5.03%
Change (1 day)
8.17%
Change (1 year)
Bio-Techne Corporation is an American holding company for biotechnology and clinical diagnostic brands. The company's brands portfolio includes R&D Systems, Novus Biologicals, Tocris Bioscience, ProteinSimple, Exosome Diagnostics, BiosPacific, Cliniqa, Advanced Cell Diagnostics, RNA Medical, Bionostics and BostonBiochem.

Number of shares outstanding for Bio-Techne (TECH)

Number of shares outstanding as of September 2024 : 157,309,000

According to Bio-Techne's latest financial reports and stock price the company's current number of shares outstanding is 157,309,000. At the end of 2024 the company had 157,309,000 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.

Shares outstanding history for Bio-Techne from 2022 to 2024

Shares Outstanding at the end of each year

Year Shares Outstanding Change
20240.15 B-0.14%
20230.15 B0.33%
20220.15 B

Shares Outstanding for similar companies or competitors

Company Shares Outstanding differencediff. Country
382,000,000 142.83%๐Ÿ‡บ๐Ÿ‡ธ USA
28,395,000-81.95%๐Ÿ‡บ๐Ÿ‡ธ USA
289,562,000 84.07%๐Ÿ‡บ๐Ÿ‡ธ USA
737,600,000 368.89%๐Ÿ‡บ๐Ÿ‡ธ USA
221,847,000 41.03%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
1,089,000,000 592.27%๐Ÿ‡บ๐Ÿ‡ธ USA
51,214,000-67.44%๐Ÿ‡บ๐Ÿ‡ธ USA